MedTrace Logo

An Open-label Trial of the Effect of Valacyclovir on Plasma HIV-1 Levels Among HIV-1 Seropositive and HSV-1/2 Seronegative Persons

NCT01059084 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2012-12-05

No results posted yet for this study

Summary

The purpose of this study is to look at the effect of daily herpes medication, valacyclovir, on HIV levels in the blood in persons who are HIV positive and do not have oral or genital herpes.

Conditions

  • HIV
  • HIV Infections

Interventions

DRUG

Valacyclovir

1000 mg tid

Sponsors & Collaborators

Principal Investigators

  • Anna Wald, MD, MPH · University of Washington

Study Design

Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-01-31
Primary Completion
2012-12-31
Completion
2012-12-31

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01059084 on ClinicalTrials.gov